Results 141 to 150 of about 33,479 (238)

Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent

open access: yes, 1997
In this study, we attempted to prepare microspheres from a microbial biodegradable polyester, i.e. polyhydroxybutyrate (PHB) as a potential chemoembolization agent.
Dou, Y   +5 more
core  

Oily Chemoembolization of Pancreatic Head Adenocarcinoma

open access: yes, 2020
Oily chemoembolization is a known method of treatment for hepatic malignancies but was never used for pancreatic cancer. We report the case of a 48-year-old patient with unresectable adenocarcinoma of the pancreatic head treated by repeated ...
P G Tarazov, A V Pavlovskij, D A Granov
core  

Safety and efficacy assessment of transarterial chemoembolization using drug-eluting beads in patients with hepatocellular carcinoma and arterioportal shunt: a single-center experience

open access: yes, 2019
Yu-dong Xiao, Cong Ma, Zi-shu Zhang,* Jun Liu* Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha 410011, China *These authors contributed equally to this work Objective: To evaluate the feasibility and ...
Liu J, Ma C, Xiao YD, Zhang ZS
core  

Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma

open access: yes, 2019
Hui Xie,1 Shengtao Tian,1 Li Cui,2 Jieyu Yan,2 Yanhua Bai,2 Xiaohui Li,2 Maoqiang Wang,2 Fangfang Zhang,3 Feng Duan21Department of Interventional Therapy, The Fifth Medical Center of PLA General Hospital, Beijing, 100039, People’s Republic of China;
Wang M   +8 more
core  

Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis

open access: yes, 2015
Xin Tian,1 Ying Dai,1 Da-qing Wang,2 Li Zhang,1 Cheng-guang Sui,1 Fan-dong Meng,1 Shen-yi Jiang,1 Yun-peng Liu,1 You-hong Jiang1 1Molecular Oncology Laboratory of Cancer Research Institute, The First Affiliated Hospital of China Medical ...
Meng F   +8 more
core  

Selective cTACE to a segment target hepatocellular carcinoma lesion during atezolizumab plus bevacizumab therapy achieving delayed hypovascularization and shrinkage of non-target intrahepatic lesions: a case report. [PDF]

open access: yesOxf Med Case Reports
Hara H   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy